Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.

Gallagher IJ, Scheele C, Keller P, Nielsen AR, Remenyi J, Fischer CP, Roder K, Babraj J, Wahlestedt C, Hutvagner G, Pedersen BK, Timmons JA.

Genome Med. 2010 Feb 1;2(2):9. doi: 10.1186/gm130.

2.

MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus.

Takahashi P, Xavier DJ, Evangelista AF, Manoel-Caetano FS, Macedo C, Collares CV, Foss-Freitas MC, Foss MC, Rassi DM, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Gene. 2014 Apr 15;539(2):213-23. doi: 10.1016/j.gene.2014.01.075. Epub 2014 Feb 11.

PMID:
24530307
3.

Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats.

Keller J, Ringseis R, Eder K.

BMC Genomics. 2014 Jun 21;15:512. doi: 10.1186/1471-2164-15-512.

4.

MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes.

Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J, Gauguier D, McCarthy MI, Lindgren CM.

BMC Med Genomics. 2009 Aug 18;2:54. doi: 10.1186/1755-8794-2-54.

5.

The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway.

Granjon A, Gustin MP, Rieusset J, Lefai E, Meugnier E, Güller I, Cerutti C, Paultre C, Disse E, Rabasa-Lhoret R, Laville M, Vidal H, Rome S.

Diabetes. 2009 Nov;58(11):2555-64. doi: 10.2337/db09-0165. Epub 2009 Aug 31.

6.

High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells.

Beer L, Seemann R, Ristl R, Ellinger A, Kasiri MM, Mitterbauer A, Zimmermann M, Gabriel C, Gyöngyösi M, Klepetko W, Mildner M, Ankersmit HJ.

BMC Genomics. 2014 Sep 25;15:814. doi: 10.1186/1471-2164-15-814.

7.
8.

Identification of differences in microRNA transcriptomes between porcine oxidative and glycolytic skeletal muscles.

Liu Y, Li M, Ma J, Zhang J, Zhou C, Wang T, Gao X, Li X.

BMC Mol Biol. 2013 Feb 18;14:7. doi: 10.1186/1471-2199-14-7.

10.

Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells.

Cardinali B, Castellani L, Fasanaro P, Basso A, Alemà S, Martelli F, Falcone G.

PLoS One. 2009 Oct 27;4(10):e7607. doi: 10.1371/journal.pone.0007607.

11.

Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis.

Xiong F, Du X, Hu J, Li T, Du S, Wu Q.

Curr Eye Res. 2014 Jul;39(7):720-9. doi: 10.3109/02713683.2013.872280. Epub 2014 Feb 6.

PMID:
24502381
12.

Inter- and intra-combinatorial regulation by transcription factors and microRNAs.

Zhou Y, Ferguson J, Chang JT, Kluger Y.

BMC Genomics. 2007 Oct 30;8:396.

13.

Expression profiling of differentiating eosinophils in bone marrow cultures predicts functional links between microRNAs and their target mRNAs.

Yang M, Eyers F, Xiang Y, Guo M, Young IG, Rosenberg HF, Foster PS.

PLoS One. 2014 May 13;9(5):e97537. doi: 10.1371/journal.pone.0097537. eCollection 2014.

14.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
15.

Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development.

Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, Meir K, Khvalevsky E, Spector Y, Rojansky N, Bentwich Z, Reubinoff BE, Galun E.

PLoS One. 2009 Oct 20;4(10):e7511. doi: 10.1371/journal.pone.0007511.

16.

miRNA and cancer; computational and experimental approaches.

Tutar Y.

Curr Pharm Biotechnol. 2014;15(5):429.

PMID:
25189575
17.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
18.

MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation.

Ortega FJ, Moreno-Navarrete JM, Pardo G, Sabater M, Hummel M, Ferrer A, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, Fernández-Real JM.

PLoS One. 2010 Feb 2;5(2):e9022. doi: 10.1371/journal.pone.0009022.

19.

Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease.

Pandey P, Qin S, Ho J, Zhou J, Kreidberg JA.

BMC Syst Biol. 2011 Apr 25;5:56. doi: 10.1186/1752-0509-5-56.

20.

CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.

Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD, Zhang L, Liao DF.

Clin Exp Pharmacol Physiol. 2009 Sep;36(9):e32-9. doi: 10.1111/j.1440-1681.2009.05207.x. Epub 2009 May 19.

PMID:
19473196
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk